eGenesis

eGenesis is a biotechnology company working at the intersection of genome engineering and transplantation to make organ transplants accessible to all. Using a multiplex CRISPR gene-editing and genome-engineering platform, eGenesis engineers porcine (pig) donor organs that are immunologically and molecularly compatible with human recipients and free of porcine endogenous retroviruses, aiming to end waitlist mortality by removing donor-organ scarcity as a barrier to transplantation. Its pipeline spans kidney, liver, and heart xenotransplantation programs; the U.S. FDA has cleared its IND for EGEN-2784, a genetically engineered porcine kidney, to begin a Phase 1/2/3 trial in patients with end-stage kidney disease. eGenesis is a private, venture-backed company (investors include Lux Capital). This API Evangelist profile tracks the company for network discovery; eGenesis publishes a corporate and scientific web presence but does not currently expose a public developer API.

eGenesis is profiled on the APIs.io network. Tagged areas include Company, Biotech, Xenotransplantation, Gene Editing, and Genome Engineering.

eGenesis’ developer surface includes engineering blog, support, and 9 more developer resources.

🌐 Visit website 📡 Source on GitHub

15.0/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

AccessApproval

0 APIs

CompanyBiotechXenotransplantationGene EditingGenome EngineeringOrgan TransplantationLife SciencesHealthcare

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 15.0/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/egenesis: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 5

The organization behind the API

Website

About

Blog

X-Careers

LinkedIn

Other 2

Properties that don't map to a standard resource type

X-Science

X-Science

X-Pipeline

X-Pipeline

Source (apis.yml)

aid: egenesis
name: eGenesis
description: eGenesis is a biotechnology company working at the intersection of genome engineering and transplantation to
  make organ transplants accessible to all. Using a multiplex CRISPR gene-editing and genome-engineering platform, eGenesis
  engineers porcine (pig) donor organs that are immunologically and molecularly compatible with human recipients and free
  of porcine endogenous retroviruses, aiming to end waitlist mortality by removing donor-organ scarcity as a barrier to transplantation.
  Its pipeline spans kidney, liver, and heart xenotransplantation programs; the U.S. FDA has cleared its IND for EGEN-2784,
  a genetically engineered porcine kidney, to begin a Phase 1/2/3 trial in patients with end-stage kidney disease. eGenesis
  is a private, venture-backed company (investors include Lux Capital). This API Evangelist profile tracks the company for
  network discovery; eGenesis publishes a corporate and scientific web presence but does not currently expose a public developer
  API.
url: https://raw.githubusercontent.com/api-evangelist/egenesis/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: approval
  trial: false
  try_now: false
  public: false
  label: Requires approval
  confidence: medium
  source: []
  generated: '2026-07-22'
  method: derived
image: https://egenesisbio.com/favicon.ico
x-type: company
x-source: vc-portfolio
x-backed-by:
- lux-capital
x-tier: stub
x-tier-reason: portfolio-lead
x-no-public-api: true
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotech
- Xenotransplantation
- Gene Editing
- Genome Engineering
- Organ Transplantation
- Life Sciences
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/egenesis-domain-security.yml
- type: Website
  url: https://egenesisbio.com
- type: About
  url: https://egenesisbio.com/about
- type: Blog
  url: https://egenesisbio.com/news-media
- type: Support
  url: https://egenesisbio.com/contact
- type: TermsOfService
  url: https://egenesisbio.com/terms-of-use
- type: PrivacyPolicy
  url: https://egenesisbio.com/privacy-policy
- type: X-Science
  url: https://egenesisbio.com/science
- type: X-Pipeline
  url: https://egenesisbio.com/pipeline
- type: X-Careers
  url: https://egenesisbio.com/careers
- type: LinkedIn
  url: https://www.linkedin.com/company/egenesisbio/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence